INMD
Price
$15.16
Change
-$0.05 (-0.33%)
Updated
Jul 3 closing price
Capitalization
1.82B
18 days until earnings call
QTRX
Price
$6.98
Change
+$0.06 (+0.87%)
Updated
Jul 3 closing price
Capitalization
907.82M
36 days until earnings call
Interact to see
Advertisement

INMD vs QTRX

Header iconINMD vs QTRX Comparison
Open Charts INMD vs QTRXBanner chart's image
InMode
Price$15.16
Change-$0.05 (-0.33%)
Volume$595.95K
Capitalization1.82B
Quanterix
Price$6.98
Change+$0.06 (+0.87%)
Volume$383.53K
Capitalization907.82M
INMD vs QTRX Comparison Chart in %
Loading...
INMD
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
QTRX
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
View a ticker or compare two or three
VS
INMD vs. QTRX commentary
Jul 06, 2025

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is INMD is a Buy and QTRX is a StrongBuy.

Interact to see
Advertisement
COMPARISON
Comparison
Jul 06, 2025
Stock price -- (INMD: $15.16 vs. QTRX: $6.98)
Brand notoriety: INMD and QTRX are both not notable
Both companies represent the Medical Specialties industry
Current volume relative to the 65-day Moving Average: INMD: 52% vs. QTRX: 50%
Market capitalization -- INMD: $1.82B vs. QTRX: $907.82M
INMD [@Medical Specialties] is valued at $1.82B. QTRX’s [@Medical Specialties] market capitalization is $907.82M. The market cap for tickers in the [@Medical Specialties] industry ranges from $3.82T to $0. The average market capitalization across the [@Medical Specialties] industry is $8.58B.

Long-Term Analysis

It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is undervalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).

INMD’s FA Score shows that 0 FA rating(s) are green whileQTRX’s FA Score has 1 green FA rating(s).

  • INMD’s FA Score: 0 green, 5 red.
  • QTRX’s FA Score: 1 green, 4 red.
According to our system of comparison, INMD is a better buy in the long-term than QTRX.

Short-Term Analysis

It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.

If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.

INMD’s TA Score shows that 4 TA indicator(s) are bullish while QTRX’s TA Score has 5 bullish TA indicator(s).

  • INMD’s TA Score: 4 bullish, 5 bearish.
  • QTRX’s TA Score: 5 bullish, 4 bearish.
According to our system of comparison, QTRX is a better buy in the short-term than INMD.

Price Growth

INMD (@Medical Specialties) experienced а +7.75% price change this week, while QTRX (@Medical Specialties) price change was +6.24% for the same time period.

The average weekly price growth across all stocks in the @Medical Specialties industry was +1.93%. For the same industry, the average monthly price growth was +1.81%, and the average quarterly price growth was -0.17%.

Reported Earning Dates

INMD is expected to report earnings on Oct 22, 2025.

QTRX is expected to report earnings on Nov 05, 2025.

Industries' Descriptions

@Medical Specialties (+1.93% weekly)

Medical specialties are companies that make equipment used by the health care industry. Equipment manufactured and distributed by these companies include dialysis machines, blood analysis equipment, surgical equipment, dental instruments, and diagnostic tools, among other items. Large companies typically aim to produce and distribute high-quality products across a broad market spectrum. Smaller firms are more likely to specialize in a particular market segment. Due to the industry’s close association with medical treatments, they typically have low sensitivity to macroeconomic fluctuations. Within this industry, Abbott Laboratories, Medtronic Plc and Thermo Fisher Scientific Inc. are some of the companies with multi-billion market capitalizations in the U.S. stock markets.

SUMMARIES
Loading...
FUNDAMENTALS
Fundamentals
INMD($1.82B) has a higher market cap than QTRX($908M). INMD YTD gains are higher at: -9.222 vs. QTRX (-34.337). INMD has higher annual earnings (EBITDA): 196M vs. QTRX (-39.79M). INMD has more cash in the bank: 742M vs. QTRX (321M). INMD has less debt than QTRX: INMD (9.02M) vs QTRX (41.5M). INMD has higher revenues than QTRX: INMD (492M) vs QTRX (121M).
INMDQTRXINMD / QTRX
Capitalization1.82B908M201%
EBITDA196M-39.79M-493%
Gain YTD-9.222-34.33727%
P/E Ratio9.13N/A-
Revenue492M121M407%
Total Cash742M321M231%
Total Debt9.02M41.5M22%
FUNDAMENTALS RATINGS
INMD vs QTRX: Fundamental Ratings
INMD
QTRX
OUTLOOK RATING
1..100
5050
VALUATION
overvalued / fair valued / undervalued
1..100
64
Fair valued
29
Undervalued
PROFIT vs RISK RATING
1..100
100100
SMR RATING
1..100
4093
PRICE GROWTH RATING
1..100
6154
P/E GROWTH RATING
1..100
77100
SEASONALITY SCORE
1..100
50n/a

Tickeron ratings are formulated such that a rating of 1 designates the most successful stocks in a given industry, while a rating of 100 points to the least successful stocks for that industry.

QTRX's Valuation (29) in the Pharmaceuticals Major industry is somewhat better than the same rating for INMD (64) in the null industry. This means that QTRX’s stock grew somewhat faster than INMD’s over the last 12 months.

QTRX's Profit vs Risk Rating (100) in the Pharmaceuticals Major industry is in the same range as INMD (100) in the null industry. This means that QTRX’s stock grew similarly to INMD’s over the last 12 months.

INMD's SMR Rating (40) in the null industry is somewhat better than the same rating for QTRX (93) in the Pharmaceuticals Major industry. This means that INMD’s stock grew somewhat faster than QTRX’s over the last 12 months.

QTRX's Price Growth Rating (54) in the Pharmaceuticals Major industry is in the same range as INMD (61) in the null industry. This means that QTRX’s stock grew similarly to INMD’s over the last 12 months.

INMD's P/E Growth Rating (77) in the null industry is in the same range as QTRX (100) in the Pharmaceuticals Major industry. This means that INMD’s stock grew similarly to QTRX’s over the last 12 months.

TECHNICAL ANALYSIS
Technical Analysis
INMDQTRX
RSI
ODDS (%)
Bearish Trend 4 days ago
87%
Bearish Trend 4 days ago
76%
Stochastic
ODDS (%)
Bearish Trend 4 days ago
76%
Bearish Trend 4 days ago
90%
Momentum
ODDS (%)
Bullish Trend 4 days ago
78%
Bullish Trend 4 days ago
80%
MACD
ODDS (%)
Bullish Trend 4 days ago
87%
N/A
TrendWeek
ODDS (%)
Bullish Trend 4 days ago
78%
Bullish Trend 4 days ago
80%
TrendMonth
ODDS (%)
Bullish Trend 4 days ago
79%
Bullish Trend 4 days ago
80%
Advances
ODDS (%)
Bullish Trend 5 days ago
77%
Bullish Trend 4 days ago
81%
Declines
ODDS (%)
Bearish Trend 17 days ago
78%
Bearish Trend 24 days ago
84%
BollingerBands
ODDS (%)
Bearish Trend 4 days ago
79%
Bearish Trend 4 days ago
82%
Aroon
ODDS (%)
Bearish Trend 4 days ago
70%
Bullish Trend 4 days ago
82%
View a ticker or compare two or three
Interact to see
Advertisement
INMD
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
QTRX
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
MFs / NAMEPrice $Chg $Chg %
PRJDX47.130.45
+0.96%
PGIM Jennison Global Opportunities R4
AGTIX169.871.30
+0.77%
AB Sustainable Global Thematic I
AZMAX18.100.04
+0.22%
Virtus NFJ Emerging Markets Value A
HAORX15.640.02
+0.13%
Harbor International Core Retirement
IGNYX17.30-0.02
-0.12%
Macquarie Natural Resources Y

INMD and

Correlation & Price change

A.I.dvisor indicates that over the last year, INMD has been loosely correlated with CRL. These tickers have moved in lockstep 45% of the time. This A.I.-generated data suggests there is some statistical probability that if INMD jumps, then CRL could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To INMD
1D Price
Change %
INMD100%
-0.33%
CRL - INMD
45%
Loosely correlated
-0.23%
IDXX - INMD
44%
Loosely correlated
+0.79%
RVTY - INMD
44%
Loosely correlated
+0.41%
MTD - INMD
43%
Loosely correlated
+0.28%
CNMD - INMD
43%
Loosely correlated
+0.20%
More

QTRX and

Correlation & Price change

A.I.dvisor indicates that over the last year, QTRX has been loosely correlated with TWST. These tickers have moved in lockstep 50% of the time. This A.I.-generated data suggests there is some statistical probability that if QTRX jumps, then TWST could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To QTRX
1D Price
Change %
QTRX100%
+0.87%
TWST - QTRX
50%
Loosely correlated
+1.30%
ILMN - QTRX
49%
Loosely correlated
N/A
IQV - QTRX
49%
Loosely correlated
-0.25%
RVTY - QTRX
47%
Loosely correlated
+0.41%
DHR - QTRX
45%
Loosely correlated
+0.35%
More